Application of mild therapeutic hypothermia for hearing conservation during cochlear implant surgeries

亚低温治疗在人工耳蜗植入手术中听力保护中的应用

• 批准号: 10327695
• 负责人: Suhrud M. Rajguru
• 金额: $ 40.46万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-01-11 至 2025-12-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10327695
• 关键词: Acoustic Stimulation; Acoustics; Acute; Address; Affect; Age; Apoptosis; Auditory; Auditory Brainstem Responses; Auditory area; Biological; Blood; Blood Vessels; Cadaver; Caspase; Cell Count; Cell Death; Cell Survival; Cell physiology; Child; Cisplatin; Clinical; Clinical Protocols; Cochlea; Cochlear Implants; Cochlear implant procedure; Custom; Data; Development; Devices; Electric Stimulation; Elements; Eligibility Determination; Ensure; Face; Fibrosis; Functional disorder; Future; Gender; Gene Expression; Hair Cells; Head and Neck Surgery; Hearing; Histologic; Homeostasis; Human; Hypoxia; Immunohistochemistry; Implant; Inflammation; Inflammatory; Injury; Intervention; Knowledge; Labyrinth; Lead; Link; Maintenance; Measurement; Measures; Mechanics; Mediating; Modeling; Molecular; Molecular Biology; Neurons; Noise; Operating Rooms; Operative Surgical Procedures; Organ of Corti; Outcome; Oxidative Stress; Pathway interactions; Patients; Pharmacologic Substance; Physiologic Ossification; Physiological; Pre-Clinical Model; Procedures; Protocols documentation; Publishing; Reaction; Regimen; Reperfusion Injury; Research; Residual state; Reverse Transcriptase Polymerase Chain Reaction; Rewarming; Safety; Sensorineural Hearing Loss; Sensory Hair; Signal Pathway; Speech Perception; Stria Vascularis; Structure; Synapses; System; Techniques; Technology; Temperature; Temporal bone structure; Testing; Therapeutic; Therapeutic Intervention; Time; Translations; Trauma; Tympanostomy; Work; base; clinical application; clinical translation; cytokine; design; effective therapy; experimental study; functional outcomes; hearing impairment; hearing preservation; implantation; improved; industry partner; ischemic injury; natural hypothermia; neuroprotection; next generation; otoacoustic emission; ototoxicity; pre-clinical; preservation; protective effect; public health relevance; relating to nervous system; round window; safety testing; spiral ganglion; standard of care; technological innovation; therapeutically effective; transcriptome sequencing

Project Summary More than half a million patients, including children, have benefitted from the remarkable technological breakthrough that are cochlear implants (CI). An increasing number of patients have some level of residual hearing at the time of implantation and can benefit from bimodal electro-acoustic devices. Surviving hair cell activity and as a result a functioning organ of Corti and neural substrate has recently been linked to speech perception outcomes. However, trauma during implantation leads to inflammation and oxidative stress that can exacerbate residual hearing loss. Successful translation of therapeutic interventions to limit pathophysiology of the injury have yet to be achieved. The present work will design and implement applications of localized, therapeutic hypothermia for protection of hair cells and neural substrate following CI. The specific aims are motivated by preliminary and published data showing that localized, mild hypothermia delivered to the cochlea is highly effective and safe, protecting hair cells and synaptic components, protecting the integrity of the cochlear blood-labyrinth barrier and preserving residual hearing long-term after implantation. Specific aim 1 will test safety and efficacy of cooling when applied to the cochlea and develop an optimal protocol for improved long-term functional and physiological outcomes. In specific aim 2 using molecular biology and immunohistochemistry techniques we will define the neuroprotective mechanisms underlying hypothermia. Combining the preclinical results with human cadaver temporal bone studies in specific aim 3, we will develop a device and system for human application. The system will enable delivery of optimized hypothermia therapy for residual structure and functional protection post-implant. Ensuring the survival of sensitive hair cells and neural structures in the cochlea are likely to lead to improved speech perception outcomes and will enable patients to benefit from future technologies and/or therapies. The results from this project can be further extended to other inner ear-related trauma such as ototoxicity, or noise- and blast-induced trauma.

项目概要 超过 50 万患者（包括儿童）受益于卓越的技术 人工耳蜗（CI）是一项突破。越来越多的患者有一定程度的残留 植入时的听力可以受益于双模电声装置。幸存的毛细胞 活动以及由此产生的柯蒂功能器官和神经基质最近与言语有关 感知结果。然而，植入过程中的创伤会导致炎症和氧化应激 加剧残余听力损失。成功转化治疗干预措施以限制病理生理学 伤害尚未达到。目前的工作将设计和实现本地化的应用程序， 治疗性低温可保护 CI 后的毛细胞和神经基质。具体目标是 初步和已发表的数据显示，局部轻度低温传递至耳蜗 高效、安全，保护毛细胞和突触成分，保护毛细胞的完整性 耳蜗血迷路屏障并在植入后长期保留残余听力。具体目标1将 测试应用于耳蜗的冷却的安全性和有效性，并制定最佳方案以改善 长期功能和生理结果。在具体目标 2 中，利用分子生物学和 通过免疫组织化学技术，我们将定义体温过低的神经保护机制。 将临床前结果与特定目标 3 中的人类尸体颞骨研究相结合，我们将开发 供人类应用的设备和系统。该系统将能够提供优化的低温治疗 用于植入后的残余结构和功能保护。确保敏感毛细胞的存活和 耳蜗的神经结构可能会改善言语感知结果，并使 患者从未来的技术和/或疗法中受益。该项目的成果可进一步 扩展到其他与内耳相关的创伤，例如耳毒性或噪音和爆炸引起的创伤。